Quantitative proteomic analysis to identify differentially expressed proteins in patients with epilepsy

Area of Science:

• Neuroscience
• Biochemistry
• Proteomics

Background:

• Epilepsy affects a significant portion of individuals experiencing a first seizure.
• Current diagnostic methods lack biomarkers to predict epilepsy development (epileptogenesis).
• Identifying early markers is crucial for timely intervention and treatment.

Purpose of the Study:

• To identify potential plasma biomarkers for epilepsy and epileptogenesis in adults with new-onset seizures.
• To utilize quantitative proteomic analysis for biomarker discovery.
• To differentiate individuals who will develop epilepsy from those with isolated seizures.

Main Methods:

• Collected plasma samples from 55 adults with new-onset seizures.
• Performed quantitative proteomic analysis using tandem mass tags and mass spectrometry.
• Analyzed protein expression, identifying dysregulated proteins with a p-value <0.05 and a fold change of ≥20%.

Main Results:

• 63.6% of the cohort developed epilepsy within two years.
• Identified 41 significantly dysregulated proteins in epilepsy patients compared to controls.
• Detected proteins are potentially involved in pathways linked to epileptogenesis.

Conclusions:

• This pilot study provides a list of candidate proteins for epilepsy biomarker research.
• The identified proteins warrant further investigation in targeted, confirmatory studies.
• Plasma proteome profiling offers a promising avenue for understanding epileptogenesis.